Cite
HARVARD Citation
Pieber, T. et al. (2019). Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial. Lancet. 7 (7), pp. 528-539. [Online].